IRIS Institutional Research Information System - OPENBS Open Archive UniBS

CELLA, CHIARA ALESSANDRA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.057
AS - Asia 216
EU - Europa 212
OC - Oceania 3
SA - Sud America 1
Totale 1.489
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.050
SG - Singapore 90
HK - Hong Kong 72
UA - Ucraina 49
DE - Germania 31
FI - Finlandia 28
RU - Federazione Russa 28
CN - Cina 27
IE - Irlanda 27
TR - Turchia 20
IT - Italia 18
GB - Regno Unito 17
CA - Canada 6
BE - Belgio 3
AT - Austria 2
AU - Australia 2
JP - Giappone 2
LT - Lituania 2
AE - Emirati Arabi Uniti 1
BR - Brasile 1
CR - Costa Rica 1
ES - Italia 1
FR - Francia 1
ID - Indonesia 1
KG - Kirghizistan 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
NZ - Nuova Zelanda 1
RS - Serbia 1
SE - Svezia 1
TM - Turkmenistan 1
VN - Vietnam 1
Totale 1.489
Salva come PNG Salva come JPEG
Città #
Fairfield 170
Chandler 131
Woodbridge 83
Singapore 77
Seattle 75
Hong Kong 72
Wilmington 69
Ashburn 67
Houston 67
Princeton 54
Cambridge 46
Jacksonville 43
Dublin 27
Helsinki 27
Istanbul 20
Moscow 17
Ann Arbor 16
Shanghai 13
New York 11
San Diego 9
Des Moines 7
London 6
San Francisco 5
Frankfurt am Main 4
Los Angeles 4
Toronto 4
Beijing 3
Brussels 3
Falkenstein 2
Kilburn 2
Redwood City 2
Sabbio Chiese 2
Ashgabat 1
Auckland 1
Belgrade 1
Bishkek 1
Boardman 1
Brescia 1
Catania 1
Changchun 1
Chisinau 1
Chiswick 1
Edinburgh 1
Guangzhou 1
Harbin 1
Islington 1
Jakarta 1
Jinan 1
Lappeenranta 1
Leawood 1
Leipzig 1
Luxembourg 1
Markham 1
Melbourne 1
Milan 1
New Bedfont 1
Norwalk 1
Ottawa 1
Prescot 1
Riga 1
San José 1
Santa Clara 1
Shenyang 1
Southwark 1
Sydney 1
Tianjin 1
Tokyo 1
Wandsworth 1
Totale 1.174
Salva come PNG Salva come JPEG
Nome #
Systemic therapies in patients with advanced well-differentiated pancreatic neuroendocrine tumors (PanNETs): When cytoreduction is the aim. A critical review with meta-analysis 100
Pharmacodynamics, clinical findings and approval status of current and emerging tyrosine-kinase inhibitors for pancreatic neuroendocrine tumors 81
Should platinum-based chemotherapy be preferred for germline BReast CAncer genes (BRCA) 1 and 2-mutated pancreatic ductal adenocarcinoma (PDAC) patients? A systematic review and meta-analysis 74
Primary hepatic lymphoma in a patient with previous rectal adenocarcinoma: a case report and discussion of etiopathogenesis and diagnostic tools 72
Treatments for colorectal liver metastases: A new focus on a familiar concept 67
Evaluation of Biomarkers for the Prediction of Venous Thromboembolism in Ambulatory Cancer Patients 61
Adjuvant Treatment for Locally Advanced Rectal Cancer Patients After Preoperative Chemoradiotherapy: When, and for Whom? 58
Dual inhibition of mTOR pathway and VEGF signalling in neuroendocrine neoplasms: from bench to bedside 57
Digital Ischemia in Patients with Solid Tumors: a Case Report and Review of the Literature 57
The role of multimodal treatment in patients with advanced lung neuroendocrine tumors 56
Bevacizumab maintenance in metastatic colorectal cancer: How long? 55
Primary prevention of cancer-related thrombosis: special focus on ambulatory patients 53
Systemic Chemotherapy for Advanced Rare Pancreatic Histotype Tumors: A Retrospective Multicenter Analysis 53
Oxaliplatin-Based Chemotherapy in Advanced Neuroendocrine Tumors: Clinical Outcomes and Preliminary Correlation with Biological Factors 51
FOLFIRI in patients with locally advanced or metastatic pancreatic or biliary tract carcinoma: a monoinstitutional experience 50
Should cT2N0M0 be managed as a localized or locally advanced esophageal carcinoma? 49
Preventing Venous Thromboembolism in Ambulatory Cancer Patients: The ONKOTEV Study 49
Predictive Markers of Response to Everolimus and Sunitinib in Neuroendocrine Tumors 48
Metronomic and metronomic-like therapies in neuroendocrine tumors - Rationale and clinical perspectives 48
Basaloid squamous cell carcinoma: a rare tumor at the esophagogastric junction and an unexpected durable complete response to FOLFOX-4 47
HER2/HER3 pathway in biliary tract malignancies; systematic review and meta-analysis: a potential therapeutic target? 47
The Italian Rare Pancreatic Exocrine Cancer Initiative 47
Successful palliative approach with high-intensity focused ultrasound in a patient with metastatic anaplastic pancreatic carcinoma: a case report 46
Lung carcinoids with high proliferative activity: Further support for the identification of a new tumor category in the classification of lung neuroendocrine neoplasms 45
High-risk human papillomavirus in anal squamous cell carcinoma: A 'conservative' leading role 43
Systemic therapy beyond first-line in advanced gastric cancer: An overview of the main randomized clinical trials 39
Tumor-to-tumor metastasis: breast cancer metastatic to thymic epithelial tumor 35
Cabozantinib in neuroendocrine tumours: tackling drug activity and resistance mechanisms 19
The pandemic within the pandemic: the surge of neuropsychological disorders in Italian children during the COVID-19 era 13
Totale 1.520
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.109
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.109
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202013 0 0 0 0 0 0 0 3 2 4 2 2
2020/2021608 0 2 0 56 244 17 39 56 57 76 27 34
2021/2022178 0 42 3 11 1 9 15 21 13 6 7 50
2022/2023290 27 0 3 50 14 83 1 32 54 0 9 17
2023/2024156 20 3 11 29 1 10 3 10 34 1 4 30
2024/2025236 0 1 1 67 43 51 48 25 0 0 0 0
Totale 1.520